NCT01944774View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

PHASE2CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pneumonia
Interventions
DRUG

Nemonoxacin 500 mg

IV Infusion, once daily for 7\~14 days

DRUG

Nemonoxacin 650 mg

IV Infusion, once daily for 7\~14 days

DRUG

Moxifloxacin 400 mg

IV Infusion, once daily for 7\~14 days

Trial Locations (2)

200040

Institute of Antibiotics, Huashan Hospital, Fundan University, Shanghai

Unknown

Far eastern memorial hospital, Taipei

All Listed Sponsors
collaborator

QPS-Qualitix

INDUSTRY

collaborator

R&G Pharma Studies Co.,Ltd.

INDUSTRY

lead

TaiGen Biotechnology Co., Ltd.

INDUSTRY

NCT01944774 - Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride | Biotech Hunter | Biotech Hunter